Skip to main content

Table 2 Clinical and traditional risk factors in patients with and without recurrent CVEs

From: Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study

Characteristics With recurrent CVEs (n = 153) Without recurrent CVEs (n = 2131) p value
Age, years 62.58 ± 9.17 58.25 ± 10.50 < 0.001
Male, n (%) 115 (75.2) 1559 (73.2) 0.637
Body mass index, kg/m2 25.85 ± 3.09 26.39 ± 3.15 0.042
BMI < 25 kg/m2 70 (45.9) 718 (33.7) 0.003
SBP, mmHg 127 ± 18 128 ± 17 0.645
SBP < 130 mmHg 78 (51.2) 1057 (49.6) 0.785
DBP, mmHg 76 ± 10 78 ± 16 0.130
DBP < 80 mmHg 72 (47.3) 889 (41.7) 0.231
Heart rate, bpm 71 ± 10 71 ± 10 0.761
Biochemical parameters
 FBG, mmol/L 7.12 ± 2.43 7.24 ± 2.31 0.526
 FBG 4.4 ~ 6.5 mmol/L 60 (38.9) 886 (41.6) 0.548
 HbA1c,  % 7.53 ± 1.37 7.38 ± 1.25 0.150
 HbA1c < 7.0% 74 (48.4) 1072 (50.3) 0.932
 TC, mmol/L 4.03 ± 1.08 4.08 ± 1.19 0.618
 HDL-C, mmol/L 0.99 ± 0.26 1.01 ± 0.27 0.325
 LDL-C, mmol/L 2.44 ± 0.93 2.45 ± 0.97 0.942
 LDL-C < 1.4 mmol/L 16 (10.6) 232 (10.9) 0.907
 TG, mmol/L 1.54 (1.17–2.12) 1.56 (1.17–2.20) 0.502
 Lp(a), mg/dL 20.44 (10.01–43.96) 14.71 (6.43–34.16) 0.002
 ApoAI, g/L 1.29 ± 0.30 1.31 ± 0.30 0.407
 ApoB, g/L 0.91 ± 0.30 0.92 ± 0.30 0.746
  1. Continuous values are summarized as mean ± SD, median (Q1–Q3) and categorical variables as n (percentage)
  2. CVEs cardiovascular events, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, HbA1c glycosylated hemoglobin, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglyceride, Lp(a) lipoprotein(a), ApoAI apolipoprotein AI, ApoB apolipoprotein B